Literature DB >> 15843882

Neuroendocrine effects on mood.

Margaret G Spinelli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15843882     DOI： 10.1007/s11154-005-6723-8

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  35 in total

Review 1.  Depression and hormone therapy.

Authors:  Margaret G Spinelli
Journal:  Clin Obstet Gynecol       Date:  2004-06       Impact factor: 2.190

2.  Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women.

Authors:  E L Klaiber; D M Broverman; W Vogel; L G Peterson; M B Snyder
Journal:  Psychoneuroendocrinology       Date:  1996-10       Impact factor: 4.905

3.  Clinical significance of premenstrual dysphoric changes.

Authors:  J Endicott; U Halbreich
Journal:  J Clin Psychiatry       Date:  1988-12       Impact factor: 4.384

4.  Modulation by estradiol of serotonin receptors in brain.

Authors:  A Biegon; B S McEwen
Journal:  J Neurosci       Date:  1982-02       Impact factor: 6.167

5.  Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.

Authors:  J K Warnock; J C Bundren
Journal:  Psychopharmacol Bull       Date:  1997

6.  Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.

Authors:  J K Warnock; J C Bundren; D W Morris
Journal:  Biol Psychiatry       Date:  1998-03-15       Impact factor: 13.382

7.  A prospective study of emotional disorders in childbearing women.

Authors:  R Kumar; K M Robson
Journal:  Br J Psychiatry       Date:  1984-01       Impact factor: 9.319

8.  Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls.

Authors:  E Eriksson; C Sundblad; P Lisjö; K Modigh; B Andersch
Journal:  Psychoneuroendocrinology       Date:  1992 May-Jul       Impact factor: 4.905

9.  Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.

Authors:  Mary F Morrison; Michael J Kallan; Thomas Ten Have; Ira Katz; Kathryn Tweedy; Michelle Battistini
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

10.  Effects of girls' hormonal status on depressive and aggressive symptoms over the course of one year.

Authors:  R L Paikoff; J Brooks-Gunn; M P Warren
Journal:  J Youth Adolesc       Date:  1991-04
View more
  9 in total

1.  Anhedonia in postpartum rats.

Authors:  Brittany M Navarre; Jillian D Laggart; Rebecca M Craft
Journal:  Physiol Behav       Date:  2010-01-12

Review 2.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

3.  The role of family history of depression and the menopausal transition in the development of major depression in midlife women: Study of women's health across the nation mental health study (SWAN MHS).

Authors:  Alicia Colvin; Gale A Richardson; Jill M Cyranowski; Ada Youk; Joyce T Bromberger
Journal:  Depress Anxiety       Date:  2017-05-10       Impact factor: 6.505

4.  An Unusual Case: The Comorbidity of Mood Disorder and 17-α-Hydroxylase Deficiency.

Authors:  Serhat Tunç; Sera Yiğiter; Kürşat Altinbaş; Erhan Kurt; Timuçin Oral
Journal:  Noro Psikiyatr Ars       Date:  2013-09-01       Impact factor: 1.339

5.  17β-estradiol differentially regulates stress circuitry activity in healthy and depressed women.

Authors:  Emily G Jacobs; Laura M Holsen; Katie Lancaster; Nikos Makris; Sue Whitfield-Gabrieli; Anne Remington; Blair Weiss; Stephen Buka; Anne Klibanski; Jill M Goldstein
Journal:  Neuropsychopharmacology       Date:  2014-08-12       Impact factor: 7.853

6.  Effects of nutraceuticals on quality of life and sexual function of perimenopausal women.

Authors:  S Caruso; S Cianci; M Cariola; V Fava; A M C Rapisarda; A Cianci
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

Review 7.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

8.  Association of sex hormones and sex hormone-binding globulin with depressive symptoms in postmenopausal women: the Multiethnic Study of Atherosclerosis.

Authors:  Laura A Colangelo; Lynette L Craft; Pamela Ouyang; Kiang Liu; Pamela J Schreiner; Erin D Michos; Susan M Gapstur
Journal:  Menopause       Date:  2012-08       Impact factor: 2.953

9.  Postpartum depression and role of serum trace elements.

Authors:  Sahabeh Etebary; Sara Nikseresht; Hamid Reza Sadeghipour; Mohammad Reza Zarrindast
Journal:  Iran J Psychiatry       Date:  2010
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.